Symbol="NRBO"
AssetType="Common Stock"
Name="Neurobo Pharmaceuticals Inc"
Description="NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company, provides therapies for coronavirus neurodegenerative and cardiometabolic diseases. The company is headquartered in Boston, Massachusetts."
CIK="1638287"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="P.O. BOX 130235, ANN ARBOR, MI, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="16331400"
EBITDA="-11054000"
PERatio="None"
PEGRatio="None"
BookValue="0.755"
DividendPerShare="0"
DividendYield="0"
EPS="-15.65"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.308"
ReturnOnEquityTTM="-0.845"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-15.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.84"
EVToRevenue="-"
EVToEBITDA="-0.333"
Beta="-0.763"
num_52WeekHigh="29.9"
num_52WeekLow="0.361"
num_50DayMovingAverage="0.485"
num_200DayMovingAverage="1.105"
SharesOutstanding="27241700"
DividendDate="2019-12-31"
ExDividendDate="None"
symbol="NRBO"
open="0.56"
high="0.65"
low="0.56"
price="0.62"
volume="1231165.00"
latest_trading_day="2023-08-11"
previous_close="0.60"
change="0.02"
change_percent="3.2527%"
aroon_positive_momentum_days="30"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="433288"
Change_recent_avg="0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-0.59"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="499"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_negative_thumbnail_id_2="1091"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="534"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_positive_thumbnail_id_1="1004"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_positive_thumbnail_id_2="653"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
